Clinical trial
Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in…
NCT00002882 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002882 |
|---|---|
| Title | Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma |
| Official title | Adjuvant Therapy for Melanoma Patients With Regional Lymph Node Metastases With Interferon Alfa-2B vs. Biochemotherapy Using Cisplatin + Vinblastine + DTIC + Interferon Plus IL-2 |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Melanoma, Skin Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | Aldesleukin (IL-2), Recombinant Interferon Alfa (IFN-A), Cisplatin, Dacarbazine, Vinblastine, Adjuvant Therapy |
| Enrollment | 140 |
| Start date | Nov 1, 1995 |
| Primary completion | Aug 1, 2003 |
| Completion | Apr 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 13, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: